Cargando…
MicroRNA-mediated regulation of KRAS in cancer
While microRNAs (miRNAs) and the KRAS oncogene are known to be dysregulated in various cancers, little is known about the role of miRNAs in the regulation of KRAS in cancer. Here we review a selection of studies published in 2014 that have contributed to our understanding of the molecular mechanisms...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263212/ https://www.ncbi.nlm.nih.gov/pubmed/25433809 http://dx.doi.org/10.1186/s13045-014-0084-2 |
_version_ | 1782348533519613952 |
---|---|
author | Kim, Minlee Slack, Frank J |
author_facet | Kim, Minlee Slack, Frank J |
author_sort | Kim, Minlee |
collection | PubMed |
description | While microRNAs (miRNAs) and the KRAS oncogene are known to be dysregulated in various cancers, little is known about the role of miRNAs in the regulation of KRAS in cancer. Here we review a selection of studies published in 2014 that have contributed to our understanding of the molecular mechanisms of KRAS regulation by miRNAs and the clinical relevance of sequence variants that may interfere with functional miRNA-mediated KRAS regulation. |
format | Online Article Text |
id | pubmed-4263212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42632122014-12-12 MicroRNA-mediated regulation of KRAS in cancer Kim, Minlee Slack, Frank J J Hematol Oncol Research Highlight While microRNAs (miRNAs) and the KRAS oncogene are known to be dysregulated in various cancers, little is known about the role of miRNAs in the regulation of KRAS in cancer. Here we review a selection of studies published in 2014 that have contributed to our understanding of the molecular mechanisms of KRAS regulation by miRNAs and the clinical relevance of sequence variants that may interfere with functional miRNA-mediated KRAS regulation. BioMed Central 2014-11-30 /pmc/articles/PMC4263212/ /pubmed/25433809 http://dx.doi.org/10.1186/s13045-014-0084-2 Text en © Kim and Slack; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Highlight Kim, Minlee Slack, Frank J MicroRNA-mediated regulation of KRAS in cancer |
title | MicroRNA-mediated regulation of KRAS in cancer |
title_full | MicroRNA-mediated regulation of KRAS in cancer |
title_fullStr | MicroRNA-mediated regulation of KRAS in cancer |
title_full_unstemmed | MicroRNA-mediated regulation of KRAS in cancer |
title_short | MicroRNA-mediated regulation of KRAS in cancer |
title_sort | microrna-mediated regulation of kras in cancer |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263212/ https://www.ncbi.nlm.nih.gov/pubmed/25433809 http://dx.doi.org/10.1186/s13045-014-0084-2 |
work_keys_str_mv | AT kimminlee micrornamediatedregulationofkrasincancer AT slackfrankj micrornamediatedregulationofkrasincancer |